Improving Walking Quality and Quantity in Osteoarthritis (IWALQQ-OA)

Sponsor
Boston University Charles River Campus (Other)
Overall Status
Suspended
CT.gov ID
NCT03064139
Collaborator
Boston University (Other), University of Delaware (Other)
62
1
2
44.8
1.4

Study Details

Study Description

Brief Summary

This study evaluates the feasibility of a mindful walking intervention for management of knee osteoarthritis. Participants will be randomly assigned to receive one of two interventions i.e. mindful walking intervention or a self-care intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: MCG
  • Behavioral: SCG
N/A

Detailed Description

People with knee osteoarthritis have low levels of physical activity, especially walking activity. They also walk with abnormal walking biomechanics that are associated with greater knee loading. Therefore, it is important to increase the levels of walking activity in people with knee osteoarthritis, but also change their walking patterns to reduce knee loading.

This study will last 12 months and participants will be randomized into 2 groups. For the first 6-months, half of the participants will attend sessions at a community location that include training in mindful walking technique. The other half will meet for the same frequency and duration at a community location for education on osteoarthritis and its management (focusing on symptom management, importance of physical activity, weight management, etc.). Both groups will also receive a wrist-worn activity monitor and a smartphone application that they will use throughout the study. After 6-months all participants will be allowed to practice on their own.

All participants will complete gait analysis, knee MRI, questionnaires, physical function assessment at baseline and at 6-months. All participants will also complete questionnaires at 3,9, and 12 months. Weekly physical activity and knee pain data will be collected using the mobile health technology for 12- months.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Improving Walking Quality and Quantity in Osteoarthritis (IWALQQ-OA): A Feasibility Study
Actual Study Start Date :
Mar 7, 2019
Anticipated Primary Completion Date :
Apr 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: MCG - Mindful Walking

Participants will be trained in mindful walking technique

Behavioral: MCG
Community-based in person group training n mindful walking over 11 sessions in 6-months+ Activity monitor with feedback on activity levels

Active Comparator: SCG - Education and Self-Care

Participants will receive education in self-management of knee OA

Behavioral: SCG
Community-based in person group education in management of knee osteoarthritis (importance of physical activity, weight management, etc.) over 11 sessions in 6 months + Activity monitor with feedback on activity levels

Outcome Measures

Primary Outcome Measures

  1. Adherence (in %) [6-months]

    Measured as % of in-person training sessions attended by participants

  2. Retention (in %) [6-months]

    Measured as the % of participants returning for the post-intervention assessment

Secondary Outcome Measures

  1. Medial knee contact force during walking (in Newton) [Change from baseline to 6-months]

    Medial knee contact force derived using an EMG-Driven musculoskeletal model

  2. Average Daily Activity Count [Change from baseline to 6-months]

    Measured using an activity monitor worn by the participants

  3. Knee injury and Osteoarthritis Outcome Score (KOOS) Pain Subscale [Change from baseline to 6-months]

    Patient-reported outcome

Other Outcome Measures

  1. Arthritis Self Efficacy Scale (ASES) [Change from baseline to 6-months]

    Patient reported outcome

  2. Five Facet Mindfulness Questionnaire (FFMQ) [Change from baseline to 6-months]

    Patient reported outcome

  3. Multidimensional Assessment of Interoceptive Awareness (MAIA) questionnaire [Change from baseline to 6-months]

    Patient reported outcome

  4. 30 second chair stand test (in counts) [Change from baseline to 6-months]

    Number of time a participant can stand from a chair

  5. 40 meter fast paced walk test (in seconds) [Change from baseline to 6-months]

    Time taken to cover 40 meters while walking at a fast pace

  6. Stair Climbing Test (in seconds) [Change from baseline to 6-months]

    Time taken to ascend and descend a set of stairs

  7. Knee cartilage composition [Change from baseline to 6-months]

    MRI t1rho and t2 relaxation times

  8. Pain sensitization [Change from baseline to 6-months]

    Pressure pain threshold, Temporal summation, and conditioned pain modulation

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age 50-80 years

  • BMI ≤40 kg/m2

  • Meet American College of Rheumatology clinical and/or clinical+radiographic criteria for knee osteoarthritis

  • Knee pain score ≥ 4 during last week

  • Predominantly medial knee pain

  • Predominantly medial knee radiographic osteoarthritis with or without radiographic patellofemoral osteoarthritis

  • Ability to ambulate for a minimum of 20 minutes, without any assistive device

  • Available for the study duration

  • Own a smartphone

  • Can speak and understand English

Exclusion Criteria:
  • Contraindications to exercise

  • Using orthotics for knee pain such as knee braces, wedge insoles

  • Knee injection in previous 3-months

  • Currently receiving physical therapy for knee pain

  • Planning major treatment for knee pain (e.g., physical therapy, surgery) in next 6 months

  • Self-reported joint diseases like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout, etc.

  • Self-reported total joint replacement in any lower extremity joint

  • Self-reported neurological conditions like stroke, Parkinson's disease, etc.

  • Self-reported muscular disease like muscle dystrophy

  • Self-reported musculoskeletal or neurologic conditions that affect gait.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Boston University Boston Massachusetts United States 02215

Sponsors and Collaborators

  • Boston University Charles River Campus
  • Boston University
  • University of Delaware

Investigators

  • Principal Investigator: Deepak Kumar, PT, PhD, Boston University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Deepak Kumar, Assistant Professor, Boston University Charles River Campus
ClinicalTrials.gov Identifier:
NCT03064139
Other Study ID Numbers:
  • 4428E
First Posted:
Feb 24, 2017
Last Update Posted:
Jul 27, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Deepak Kumar, Assistant Professor, Boston University Charles River Campus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2021